Clearmind Medicine Inc (NASDAQ:CMND) shares are trading lower by 53% to $0.18 Thursday morning after the company announced pricing of a $2.25 million public offering.

The offering is expected to close on September 18, subject to the satisfaction of customary closing conditions.

The company says it expects to use the net proceeds from the offering, for general corporate purposes. 

This may include operating expenses, research and development, including clinical and pre-clinical testing of our product candidates, working capital, future acquisitions and general capital expenditures.

According to data from Benzinga Pro, CMND has a 52-week high of $6.10 and a 52-week low of $0.18.